TrialBMC psychiatry2013

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.

Lenard A Adler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.